On Telegram · @iinewswire

Get stock alerts on Telegram

Daily news, podcast drops, and featured-company updates as they post.

Join channel

Latest News

View archive →
Bear ETFs ZSL and JDST Continue to Gain Ground, Signaling Ongoing Pressure on Silver and Junior Miners - Buying Opportunity for Bulls?
Gold and Mining

Bear ETFs ZSL and JDST Continue to Gain Ground, Signaling Ongoing Pressure on Silver and Junior Miners - Buying Opportunity for Bulls?

Bear ETFs ZSL and JDST continue to gain as silver and junior gold miners stay under pressure - InvestorIdeas follow-up on the May 15 surge and outlook for bulls.

May 19, 2026

(Nasdaq: AMST) Stock Catalyst: Amesite's NurseMagic Secures Record 2,700-Census Home Care Enterprise Customer
Technology

(Nasdaq: AMST) Stock Catalyst: Amesite's NurseMagic Secures Record 2,700-Census Home Care Enterprise Customer

Amesite (Nasdaq: AMST) shares surge over 126% after the company's AI nurse documentation platform NurseMagic secures its largest enterprise customer to date - a 2,700-patient home care deployment.

May 19, 2026

Trump's Real Problem Is the Bond Market
Markets

Trump's Real Problem Is the Bond Market

deVere Group's Nigel Green warns the bond market is fast becoming Trump's biggest problem as Treasury yields spike, oil surges and investors dump debt.

May 18, 2026

Dollar, Yields and Friday's Repricing
Markets

Dollar, Yields and Friday's Repricing

Rising Treasury yields and a stronger US dollar pressure stocks as investors weigh inflation risks, AI leadership and weakening market breadth.

May 18, 2026

What Trump and Xi Chose NOT to Say on Trade Will Worry Global Markets
Markets

What Trump and Xi Chose NOT to Say on Trade Will Worry Global Markets

deVere Group CEO Nigel Green warns global investors that the Trump-Xi summit produced optics rather than resolution, with rare earths, semiconductors, tariffs and Taiwan all left unaddressed.

May 15, 2026

HCW Biologics Inc.'s (NASDAQ: HCWB) Big Gains on Q1 Revenue - Surges 493% to $6.53M
Biotechnology

HCW Biologics Inc.'s (NASDAQ: HCWB) Big Gains on Q1 Revenue - Surges 493% to $6.53M

HCW Biologics (NASDAQ: HCWB) shares surge on Q1 2026 results: revenue up 493% to $6.5M driven by a worldwide HCW11-006 license to Beijing Trimmune, plus an equity stake and progress on the HCW9302 alopecia areata trial.

May 15, 2026